Back to User profile » Prof. Dr. Silverio Tomao
Papers published by Prof. Dr. Silverio Tomao:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
![](cr_data/cache/article_graphical_abstract/s372776/graphical_abstract.jpg)
Arrivi G, Verrico M, Roberto M, Barchiesi G, Faggiano A, Marchetti P, Mazzuca F, Tomao S
Cancer Management and Research 2022, 14:3507-3523
Published Date: 21 December 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The Potential Role of Genomic Signature in Stage II Relapsed Colorectal Cancer (CRC) Patients: A Mono-Institutional Study
Roberto M, Arrivi G, Pilozzi E, Montori A, Balducci G, Mercantini P, Laghi A, Ierinò D, Panebianco M, Marinelli D, Tomao S, Marchetti P, Mazzuca F
Cancer Management and Research 2022, 14:1353-1369
Published Date: 7 April 2022
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Triple-negative breast cancer: new perspectives for targeted therapies
Tomao F, Papa A, Zaccarelli E, Rossi L, Caruso D, Minozzi M, Vici P, Frati L, Tomao S
OncoTargets and Therapy 2015, 8:177-193
Published Date: 16 January 2015
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Angiogenesis and antiangiogenic agents in cervical cancer
Tomao F, Papa A, Rossi L, Zaccarelli E, Caruso D, Zoratto F, Benedetti Panici P, Tomao S
OncoTargets and Therapy 2014, 7:2237-2248
Published Date: 3 December 2014
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Metastatic colorectal cancer first-line treatment with bevacizumab: the impact of K-ras mutation
Rossi L, Veltri E, Zullo A, Zoratto F, Colonna M, Longo F, Mottolese M, Giannarelli D, Ruco L, Marchetti P, Romiti A, Barucca V, Giannini G, Bianchi L, Tomao S
OncoTargets and Therapy 2013, 6:1761-1769
Published Date: 29 November 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Factors influencing choice of chemotherapy in metastatic colorectal cancer (mCRC)
Rossi L, Vakiarou F, Zoratto F, Bianchi L, Papa A, Basso E, Verrico M, Lo Russo G, Evangelista S, Rinaldi G, Perrone-Congedi F, Spinelli GP, Stati V, Caruso D, Prete A, Tomao S
Cancer Management and Research 2013, 5:377-385
Published Date: 19 November 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Efficacy and safety analysis of once per cycle pegfilgrastim and daily lenograstim in patients with breast cancer receiving adjuvant myelosuppressive chemotherapy FEC 100: a pilot study
Rossi L, Tomao F, Lo Russo G, Papa A, Zoratto F, Marzano R, Basso E, Giordani E, Verrico M, Ricci F, Pasciuti G, Francini E, Tomao S
Therapeutics and Clinical Risk Management 2013, 9:457-462
Published Date: 11 November 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current status of bevacizumab in advanced ovarian cancer
Tomao F, Papa A, Rossi L, Caruso D, Benedetti Panici P, Venezia M, Tomao S
OncoTargets and Therapy 2013, 6:889-899
Published Date: 22 July 2013
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
Zoratto F, Rossi L, Zullo A, Papa A, Zaccarelli E, Tomao L, Giordani E, Colonna M, Baiano G, Tomao S
OncoTargets and Therapy 2012, 5:199-211
Published Date: 24 September 2012
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer
Evelina Miele, Gian Paolo Spinelli, Ermanno Miele, Federica Tomao, Silverio Tomao
International Journal of Nanomedicine 2009, 4:99-105
Published Date: 27 April 2009